INTCO MEDICAL(SZ:300677) Sou Hu Cai Jing·2025-08-20 12:49Core Viewpoint - The stock of Yingke Medical (300677) has shown a slight decline, with a closing price of 37.03 yuan on August 20, 2025, reflecting a decrease of 0.11% [1] Group 1: Stock Performance and Trading Data - On August 20, 2025, the stock experienced a turnover rate of 3.24%, with a trading volume of 150,800 hands and a total transaction value of 554 million yuan [1] - The net outflow of main funds was 22.35 million yuan, accounting for 4.03% of the total transaction value, while retail investors saw a net inflow of 50.99 million yuan, representing 9.2% of the total transaction value [1][2] Group 2: Recent Fund Flow Overview - Over the past five days, the stock has seen varying fund flows, with significant net inflows from retail investors on August 20, 2025, contrasting with net outflows from both main and speculative funds [2] - The stock's closing prices and changes over the last five days indicate a general downward trend, with the most significant drop occurring on August 19, 2025, at -1.70% [2] Group 3: Company Financial Metrics and Industry Comparison - Yingke Medical has a total market value of 24.247 billion yuan, with a net asset value of 18.042 billion yuan, and a net profit of 353 million yuan, ranking 9th, 4th, and 7th respectively in the medical device industry [3] - The company reported a gross margin of 24.16% and a net profit margin of 14.49%, with a return on equity (ROE) of 2.17%, indicating a competitive position in the industry [3] - For Q1 2025, the company achieved a main revenue of 2.494 billion yuan, reflecting a year-on-year increase of 13.2%, and a net profit growth of 48.08% [3] Group 4: Analyst Ratings and Target Price - In the last 90 days, four institutions have rated Yingke Medical with a "buy" recommendation, and the average target price set by these institutions is 33.24 yuan [4]